Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 129, Issue 19
May 11 2017
Issue Cover

Table of Contents

INSIDE BLOOD COMMENTARIES

INSIDE BLOOD COMMENTARY
Rituximab immunotherapy: it’s getting personal
Clinical Trials & Observations
Mitch A. Phelps
View Articletitled, Rituximab immunotherapy: it’s getting personal
INSIDE BLOOD COMMENTARY
Neutrophils: positive or negative?
Ronald P. Taylor
View Articletitled, Neutrophils: positive or negative?
INSIDE BLOOD COMMENTARY
A mitochondrial drug to treat AML
Paolo Pinton
View Articletitled, A mitochondrial drug to treat AML
INSIDE BLOOD COMMENTARY
Indoxyl sulfate, a uremic trigger for platelets
Maribel Diaz-Ricart
View Articletitled, Indoxyl sulfate, a uremic trigger for platelets
INSIDE BLOOD COMMENTARY
Mobilizing plasmacytoid dendritic cells
Edmund K. Waller
View Articletitled, Mobilizing plasmacytoid dendritic cells

REVIEW ARTICLE

Vitamin B12 deficiency from the perspective of a practicing hematologist
Clinical Trials & Observations
Ralph Green
View Articletitled, Vitamin B<sub>12</sub> deficiency from the perspective of a practicing hematologist

CLINICAL TRIALS AND OBSERVATIONS

Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL
Clinical Trials & Observations
Paul M. Barr,Jennifer R. Brown,Peter Hillmen,Susan O'Brien,Jacqueline C. Barrientos,Nishitha M. Reddy,Steven Coutre,Stephen P. Mulligan,Ulrich Jaeger,Richard R. Furman,Florence Cymbalista,Marco Montillo,Claire Dearden,Tadeusz Robak,Carol Moreno,John M. Pagel,Jan A. Burger,Samuel Suzuki,Juthamas Sukbuntherng,George Cole,Danelle F. James,John C. Byrd
View Articletitled, Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL
Supplemental data
Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report
Clinical Trials & Observations
Mira Tout,Olivier Casasnovas,Michel Meignan,Thierry Lamy,Franck Morschhauser,Gilles Salles,Emmanuel Gyan,Corinne Haioun,Mélanie Mercier,Pierre Feugier,Sami Boussetta,Gilles Paintaud,David Ternant,Guillaume Cartron
View Articletitled, Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report
Supplemental data

GENE THERAPY

Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients
Aaron R. Cooper,Georgia R. Lill,Kit Shaw,Denise A. Carbonaro-Sarracino,Alejandra Davila,Robert Sokolic,Fabio Candotti,Matteo Pellegrini,Donald B. Kohn
View Articletitled, Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients
Supplemental data

IMMUNOBIOLOGY

Human neutrophils mediate trogocytosis rather than phagocytosis of CLL B cells opsonized with anti-CD20 antibodies
Rut Valgardsdottir,Irene Cattaneo,Christian Klein,Martino Introna,Marina Figliuzzi,Josée Golay
View Articletitled, Human neutrophils mediate trogocytosis rather than phagocytosis of CLL B cells opsonized with anti-CD20 antibodies
Supplemental data

LYMPHOID NEOPLASIA

Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice
Idoia García-Ramírez,Saber Tadros,Inés González-Herrero,Alberto Martín-Lorenzo,Guillermo Rodríguez-Hernández,Dalia Moore,Lucía Ruiz-Roca,Oscar Blanco,Diego Alonso-López,Javier De Las Rivas,Keenan Hartert,Romain Duval,David Klinkebiel,Martin Bast,Julie Vose,Matthew Lunning,Kai Fu,Timothy Greiner,Fernando Rodrigues-Lima,Rafael Jiménez,Francisco Javier García Criado,María Begoña García Cenador,Paul Brindle,Carolina Vicente-Dueñas,Ash Alizadeh,Isidro Sánchez-García,Michael R. Green
View Articletitled, <em>Crebbp</em> loss cooperates with <em>Bcl2</em> overexpression to promote lymphoma in mice
Supplemental data

MYELOID NEOPLASIA

Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AML
Sanduni U. Liyanage,Rose Hurren,Veronique Voisin,Gaëlle Bridon,Xiaoming Wang,ChangJiang Xu,Neil MacLean,Thirushi P. Siriwardena,Marcela Gronda,Dana Yehudai,Shrivani Sriskanthadevan,Daina Avizonis,Aisha Shamas-Din,Mark D. Minden,Gary D. Bader,Rebecca Laposa,Aaron D. Schimmer
View Articletitled, Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AML
Supplemental data

THROMBOSIS AND HEMOSTASIS

Indoxyl sulfate induces platelet hyperactivity and contributes to chronic kidney disease–associated thrombosis in mice
Ke Yang,Changhong Du,Xinmiao Wang,Fengju Li,Yang Xu,Song Wang,Shilei Chen,Fang Chen,Mingqiang Shen,Mo Chen,Mengjia Hu,Ting He,Yongping Su,Junping Wang,Jinghong Zhao
View Articletitled, Indoxyl sulfate induces platelet hyperactivity and contributes to chronic kidney disease–associated thrombosis in mice
Supplemental data

TRANSPLANTATION

Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft
Mark A. Schroeder,Michael P. Rettig,Sandra Lopez,Stephanie Christ,Mark Fiala,William Eades,Fazia A. Mir,Jin Shao,Kyle McFarland,Kathryn Trinkaus,William Shannon,Elena Deych,Jinsheng Yu,Ravi Vij,Keith Stockerl-Goldstein,Amanda F. Cashen,Geoffrey L. Uy,Camille N. Abboud,Peter Westervelt,John F. DiPersio
View Articletitled, Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft
Supplemental data
Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation
Cynthia E. Fisher,Tobias M. Hohl,Wenhong Fan,Barry E. Storer,David M. Levine,Lu Ping Zhao,Paul J. Martin,Edus H. Warren,Michael Boeckh,John A. Hansen
View Articletitled, Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation
Supplemental data

LETTERS TO BLOOD

Venetoclax and obinutuzumab in chronic lymphocytic leukemia
Clinical Trials & Observations
Kirsten Fischer,Othman Al-Sawaf,Anna-Maria Fink,Mark Dixon,Jasmin Bahlo,Simon Warburton,Thomas J. Kipps,Robert Weinkove,Sue Robinson,Till Seiler,Stephen Opat,Carolyn Owen,Javier López,Kathryn Humphrey,Rod Humerickhouse,Eugen Tausch,Lukas Frenzel,Barbara Eichhorst,Clemens-M. Wendtner,Stephan Stilgenbauer,Anton W. Langerak,Jacque J. M. van Dongen,Sebastian Böttcher,Matthias Ritgen,Valentin Goede,Mehrdad Mobasher,Michael Hallek
View Articletitled, Venetoclax and obinutuzumab in chronic lymphocytic leukemia
Supplemental data
FNDC3B is another novel partner fused to RARA in the t(3;17)(q26;q21) variant of acute promyelocytic leukemia
Chi Keung Cheng,Angela Z. Wang,Terry H. Y. Wong,Thomas S. K. Wan,Joyce S. Cheung,Radha Raghupathy,Natalie P. H. Chan,Margaret H. L. Ng
View Articletitled, FNDC3B is another novel partner fused to RARA in the t(3;17)(q26;q21) variant of acute promyelocytic leukemia
Supplemental data

BLOOD WORK

An infant with Pearson syndrome: a rare cause of congenital sideroblastic anemia and bone marrow failure
Corey P. Falcon,Thomas H. Howard
View Articletitled, An infant with Pearson syndrome: a rare cause of congenital sideroblastic anemia and bone marrow failure
Cyclin D1–negative blastoid mantle cell lymphoma exhibiting cleaved to bilobated cytomorphology
Huan-You Wang,Alexey Hodkoff
View Articletitled, Cyclin D1–negative blastoid mantle cell lymphoma exhibiting cleaved to bilobated cytomorphology
All Issues

Advertisement intended for health care professionals

Licking the wound with procoagulant vesicles
Approaching Hypercalcemia in Monoclonal Gammopathy of Undetermined Significance: Insights from the iStopMM study
CAR T-cells in autoimmunity: game changer or stepping stone?
Long-Term Efficacy and Safety of Danicopan as Add-On Therapy to Ravulizumab or Eculizumab in PNH With Significant EVH
How I treat quantitative fibrinogen disorders

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals